XML 13 R5.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
Common Stock [Member]
Additional Paid-In Capital [Member]
(Accumulated Deficit) Retained Earnings [Member]
U.S. Neurosurgical Holdings, Inc. Equity [Member]
Noncontrolling Interests [Member]
Total
Balance at Dec. 31, 2021 $ 78,000 $ 2,871,000 $ (373,000) $ 2,576,000 $ 452,000 $ 3,028,000
Balance (in shares) at Dec. 31, 2021 7,792,185          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock as compensation $ 0     0 0 0
Issuance of common stock as compensation (in shares) 50,000          
Net loss $ 0 0 (1,337,000) (1,337,000) (235,000) (1,572,000)
Balance at Dec. 31, 2022 $ 78,000 2,871,000 (1,710,000) 1,239,000 217,000 $ 1,456,000
Balance (in shares) at Dec. 31, 2022 7,842,185         7,842,185
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock as compensation $ 1,000     1,000 0 $ 1,000
Issuance of common stock as compensation (in shares) 50,000          
Net loss $ 0 0 (542,000) (542,000) (96,000) (638,000)
Balance at Jun. 30, 2023 $ 79,000 $ 2,871,000 $ (2,252,000) $ 698,000 $ 121,000 $ 819,000
Balance (in shares) at Jun. 30, 2023 7,892,185         7,892,185